evaluating germline variant gfi1-36n and its impact on dna repair in aml
Published 1 year ago • 197 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
3:10
impact of splicing factor mutations on aml treatment
-
1:23
the effect of splicing factor gene mutations on the outcomes of patients with aml
-
2:43
diagnostic tools for aml
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
14:06
interpreting myeloma tests- case studies
-
3:16
identifying low- and high-risk aml
-
4:34
the genetics of acute myeloid leukemia (aml)
-
1:31
identifying the factors in gene regulatory networking in aml
-
2:15
transcription factor alterations in aml and risk: runx, cepba & evi1
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
4:09
using transcriptional network analysis to better understand aml development and evolution
-
1:46
application of molecular genetic testing in aml
-
3:20
comparing the icc and who classifications for secondary aml and their impact on clinical practice
-
3:24
molecular profiling to determine treatment for all and aml
-
3:13
validation of 2022 diagnostic & prognostic classifications of aml
-
7:31
molecular testing for aml
-
2:11
beat aml master trial: novel precision medicine approach in aml
-
2:35
how molecular testing guides treatment in aml
-
2:35
molecular diagnosis and mrd monitoring in aml
-
3:46
variant allele frequency in patients with sf3b1-mutated mds
-
2:30
molecular testing for newly diagnosed aml